STAT3 and neoplasm: DLEC1, a tumor suppressor linked to p53, interacts with the oncogenic signaling molecule, STAT3, in response to IL-6 stimulation, blocks the JAK2/STAT3 signaling pathway, and inhibits STAT3 phosphorylation, thereby controlling tumor progression [63].